GlassScriptPhysician profile
Robert Lowell Thompson
NPI 1417101858
$205,093.13
in general payments reported to CMS, 2019-2025
6 companies · $4,524 in 2025
The $4,524 reported for 2025 was more than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $173K · 2020: $3,976 · 2021: $2,740 · 2022: $12K · 2023: $5,722 · 2024: $3,376 · 2025: $4,524.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $8,135 · Food and Beverage: $2,319 · Consulting Fee: $2,030 · Travel and Lodging: $1,138.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $8,134.62 |
| Food and Beverage | $2,318.86 |
| Consulting Fee | $2,030.00 |
| Travel and Lodging | $1,138.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paragon 28, INC. | $202,593.16 | 2019-2025 | Portfolio, Apex 3d, Ankle Fracture |
| Axogen | $1,334.52 | 2025 | |
| Stryker Corporation | $569.85 | 2024-2025 | Makoplasty, Mako, Inspace |
| Restor3d, INC. | $227.73 | 2024 | |
| Music City Medical Technologies, LLC | $215.03 | 2025 | |
| Alpha Orthopedic Systems | $152.84 | 2022-2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.